TITLE

Effect of Praziquantel Treatment during Pregnancy on Cytokine Responses to Schistosome Antigens: Results of a Randomized, Placebo-Controlled Trial

AUTHOR(S)
Tweyongyere, Robert; Mawa, Patrice A.; Ngom-wegi, Sophy; Ndibazza, Juliet; Duong, Trinh; Vennervald, Birgitte J.; Dunne, David W.; Katunguka-Rwakishaya, Eli; Elliott, Alison M.
PUB. DATE
December 2008
SOURCE
Journal of Infectious Diseases;12/15/2008, Vol. 198 Issue 12, p1870
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Praziquantel treatment of schistosomiasis boosts antischistosome responses, with type 2 helper T cell bias that may contribute to immunologically mediated killing and to protection against reinfection. Praziquantel treatment during pregnancy was recommended in 2002, but the immunological effects of the treatment had not been investigated. Methods. A cohort of 387 Schistosoma mansoni-infected women were recruited from a larger trial of deworming during pregnancy. Women were randomized to receive either praziquantel or placebo during pregnancy. Six weeks after delivery, all women received praziquantel. Cytokine responses to S. mansoni worm and egg antigens were measured in whole blood culture before and 6 weeks after each treatment. Results. Schistosome-specific cytokine responses were suppressed during pregnancy. Praziquantel treatment during pregnancy caused significant boosts in interferon-γ (IFN-γ), interleukin (IL)-2, IL-4, IL-5, IL-13, and IL-10 responses to schistosome worm antigen and in IFN-γ, IL-5, and IL-13 responses to schistosome egg antigen, but these boosts were not as substantial as those seen for women treated after delivery. Conclusion. Pregnancy suppresses a potentially beneficial boost in cytokine responses associated with praziquantel treatment. Further studies are needed on the long-term effects that treatment of schistosomiasis during pregnancy have on morbidity and resistance to reinfection among treated women and their offspring. Trial registration. International Standard Randomized Controlled Trial Number for the parent study: ISRCTN32849447.
ACCESSION #
43804687

 

Related Articles

  • Abatacept for treatment-resistant juvenile idiopathic arthritis: a withdrawal trial.  // Archives of Disease in Childhood;Dec2008, Vol. 93 Issue 12, p1053 

    The article discusses a study which concludes that abatacept is a rational alternative treatment for juvenile idiopathic arthritis. It shows two serious adverse events in the run-in open label phase, none clearly related to abatacept treatment. It found that the proportion of children in the...

  • Clinical trials in India: Where do we stand globally? Selvarajan, Sandhiya; George, Melvin; S., Suresh Kumar; Dkhar, Steven Aibor // Perspectives in Clinical Research;Jul-Sep2013, Vol. 4 Issue 3, p160 

    Aims: To evaluate the trend of clinical trials in India over the last 4 years compared to the well-established countries using clinical trial registries since the advent of clinical trial registry of India (CTRI). Materials and Methods: The data of clinical trials registered in India, United...

  • Obstacles to researching the researchers: A case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials. McKenzie, Joanne E.; Herbison, G. Peter; Roth, Paul; Paul, Charlotte // Trials;2010, Vol. 11, p28 

    Background: Recent cohort studies of randomised controlled trials have provided evidence of within-study selective reporting bias; where statistically significant outcomes are more likely to be more completely reported compared to non-significant outcomes. Bias resulting from selective reporting...

  • Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified. Claudia Castañeda; Natividad Neri; Sergio Cleto; Alejandra Talavera; Martha González; Judith Huerta-Guzmán; M. Nambo // Medical Oncology;Sep2008, Vol. 25 Issue 3, p360 

    Abstract  We performed a controlled clinical trial to define the use of a brief therapy: CMED (cyclophosphamide, etoposide, methotrexate, and dexamethasone) compared with standard CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of peripheral T-cell...

  • Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. Meissner, Karin; Distel, Hans; Mitzdorf, Ulla // BMC Medicine;2007, Vol. 5, p3 

    Background: Recent reviews on placebo effects in clinical trials suggest that objective changes following placebo treatments may not exist or, at least, have been considerably overestimated. However, the possibility that yet unidentified subsets of parameters are responsive to placebo ...

  • So-Called "Clinical Equipoise" and the Argument from Design. Gifford, Fred // Journal of Medicine & Philosophy;Mar/Apr2007, Vol. 32 Issue 2, p135 

    In this article, I review and expand upon arguments showing that Freedman's so-called "clinical equipoise" criterion cannot serve as an appropriate guide and justification for the moral legitimacy of carrying out randomized clinical trials. At the same time, I try to explain why this approach...

  • New rosacea therapeutic option. Guttman, Cheryl // Dermatology Times;May2005, Vol. 26 Issue 5, p28 

    The article presents information on a study sponsored by CollaGenex Pharmaceuticals which reveals the safety and efficacy of a subantimicrobial-dose of doxycycline for the treatment of rosacea. The subjects of the study were 134 adults with moderate-to-severe rosacea who were equally randomized...

  • Placebo orthodoxy and the double standard of care in multinational clinical research. Goldenberg, Maya // Theoretical Medicine & Bioethics;Feb2015, Vol. 36 Issue 1, p7 

    It has been almost 20 years since the field of bioethics was galvanized by a controversial series of multinational AZT trials employing placebo controls on pregnant HIV-positive women in the developing world even though a standard of care existed in the sponsor countries. The trove of ethical...

  • randomized controlled trial. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p648 

    An encyclopedia entry for "randomized controlled trial" is presented. It refers to a kind of controlled trial that is conducted to test the effectiveness of a drug or treatment in which participants are randomly assigned to study groups. Under this type of trial, one group is given a placebo, a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics